Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

No tweets found

Recent Tweets for BCRX

EnterpriseLeade @EnterpriseLeade
Alps Advisors Inc. Sells 22,977 Shares of BioCryst Pharmaceuticals, Inc. $BCRX https://t.co/vc531IHyqo
August 21st 2018, 5:08pm
MareaInformativ @MareaInformativ
Jennison Associates LLC Has $19.89 Million Stake in BioCryst Pharmaceuticals, Inc. $BCRX https://t.co/rFUZxk0o0s
August 21st 2018, 4:08pm
TheMarketsDaily @TheMarketsDaily
BioCryst Pharmaceuticals, Inc. $BCRX Receives $10.08 Consensus Target Price from Analysts https://t.co/xZjkfkv0ut
August 21st 2018, 4:08pm
CPulses @CPulses
$BCRX Continues to Shape-Up and remains technically constructive consolidating the recent thrust. #BCRX #Biotech https://t.co/5X66GMLtKW
August 21st 2018, 1:08pm
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Announce Quarterly Sales of $6.89 Million https://t.co/Z28gCehp2J
August 21st 2018, 8:08am
ChickenhawkBob @ChickenhawkBob
Bought $BCRX including E.T.P.C. tool thoughts https://t.co/EErhL7E3Ef
August 20th 2018, 12:08pm
bioswingpattern @bioswingpattern
$bcrx break and back testing 200 week moving avg. https://t.co/O4HLli1dlg
August 19th 2018, 2:08pm
TheMarketsDaily @TheMarketsDaily
Head to Head Contrast: BioCryst Pharmaceuticals $BCRX versus Vaxart $VXRT https://t.co/3HrwxN6sm7
August 19th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
BioCryst Pharmaceuticals $BCRX Rating Increased to Buy at BidaskClub https://t.co/HUmGlwRXV0
August 19th 2018, 8:08am
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.20 Per Share https://t.co/xaYnkw7WMX #stocks
August 19th 2018, 4:08am
ConsumerFeed @ConsumerFeed
Analysts Anticipate BioCryst Pharmaceuticals, Inc. $BCRX Will Post Earnings of -$0.20 Per Share https://t.co/mho8M7NSNs
August 19th 2018, 4:08am
EnterpriseLeade @EnterpriseLeade
Comparing BioCryst Pharmaceuticals $BCRX and Brainstorm Cell Therapeutics $BCLI https://t.co/LNvZEralkf
August 19th 2018, 1:08am
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Receives Average Recommendation of “Buy” from Analysts https://t.co/lVWiapGxbP #stocks
August 18th 2018, 2:08pm
TranscriptDaily @TranscriptDaily
BioCryst Pharmaceuticals, Inc. $BCRX Receives Average Recommendation of “Buy” from Analysts https://t.co/9gWTu0I0DW
August 18th 2018, 2:08pm
filing_scanner @filing_scanner
$BCRX New Insider Filing On: Sheridan William P Transaction Code: M https://t.co/Jute3Y1A09
August 18th 2018, 2:08am
WatchlistN @WatchlistN
BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/HMpcGsN4Sv
August 17th 2018, 8:08am
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals $BCRX Upgraded by ValuEngine to “Buy” https://t.co/dHKA2LG9lT
August 16th 2018, 12:08pm
dakotafinancial @dakotafinancial
BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reiterated at HC Wainwright https://t.co/jaLd8mYoib
August 16th 2018, 5:08am
EnterpriseLeade @EnterpriseLeade
$6.51 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/FjyoQCItlE
August 15th 2018, 11:08pm
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Reaches New 1-Year High at $7.49 https://t.co/rrqurkW12K
August 15th 2018, 5:08pm
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/aN7SKGigat
August 15th 2018, 5:08pm
registrarjourn @registrarjourn
BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/s85PJD3QoD
August 15th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/WaTyqQJR8m
August 15th 2018, 11:08am
ChartMill @ChartMill
Although $BCRX has an excellent technical rating, it does not offer a high quality setup at the moment.… https://t.co/IZPplBv8Re
August 15th 2018, 9:08am
TranscriptDaily @TranscriptDaily
Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX CMO Sells 62,500 Shares of Stock https://t.co/GP43fnOgyX
August 15th 2018, 5:08am
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals, Inc. Expected to Post Q3 2018 Earnings of -$0.23 Per Share $BCRX https://t.co/mPIEtSeI7z
August 15th 2018, 5:08am
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals, Inc. Expected to Post Q3 2018 Earnings of -$0.23 Per Share $BCRX https://t.co/TlmwlMIS8e
August 15th 2018, 5:08am
AmericanBanking @AmericanBanking
Research Analysts’ Recent Ratings Updates for BioCryst Pharmaceuticals $BCRX https://t.co/G3nBFZ8bIG #stocks
August 15th 2018, 4:08am
ConsumerFeed @ConsumerFeed
Research Analysts’ Recent Ratings Updates for BioCryst Pharmaceuticals $BCRX https://t.co/HabcKMVBOM
August 15th 2018, 4:08am
filing_scanner @filing_scanner
$BCRX New Insider Filing On: Sheridan William P Transaction Code: M https://t.co/Jute3XJYBz
August 14th 2018, 2:08pm
WeekHerald @WeekHerald
BioCryst Pharmaceuticals $BCRX Receives “Buy” Rating from HC Wainwright https://t.co/cH6Pl9rwY4
August 14th 2018, 10:08am
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Receives “Buy” Rating from HC Wainwright https://t.co/kWKckGKoZS
August 14th 2018, 10:08am
bbnsnews @bbnsnews
BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares of Stock https://t.co/JIW1ECdgQg
August 14th 2018, 6:08am
WatchlistN @WatchlistN
Q3 2018 Earnings Forecast for BioCryst Pharmaceuticals, Inc. $BCRX Issued By Jefferies Financial Group https://t.co/R2kGq9RNNb
August 14th 2018, 4:08am
TranscriptDaily @TranscriptDaily
BioCryst Pharmaceuticals $BCRX Raised to Buy at BidaskClub https://t.co/eOMa9MvK5f
August 14th 2018, 2:08am
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/H42N4SXJRV
August 13th 2018, 6:08pm
TheMarketsDaily @TheMarketsDaily
BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/dBkcrBx53C
August 13th 2018, 6:08pm
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals $BCRX Receives Daily Coverage Optimism Score of -0.04 https://t.co/hgG0fxKGDH
August 13th 2018, 6:08pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/vXwJ9ny3B4 #stocks
August 13th 2018, 1:08pm
OlympiaReport @OlympiaReport
William P. Sheridan Sells 62,500 Shares of BioCryst Pharmaceuticals, Inc. $BCRX Stock https://t.co/JAX5uJz117
August 13th 2018, 1:08pm
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/ZVsPgmK6w1
August 13th 2018, 1:08pm
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/jOIb44K0LS
August 13th 2018, 1:08pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals $BCRX Receives Buy Rating from HC Wainwright https://t.co/5RjXkwkaXt #stocks
August 13th 2018, 1:08pm
InsiderAlertsIA @InsiderAlertsIA
$BCRX: New Insider Filing on Senior VP - CMO WILLIAM P SHERIDAN: https://t.co/Sk6KHS4kke
August 13th 2018, 11:08am
Allstocknews @Allstocknews
$BCRX New Form 4 for BioCryst Pharmaceutical, Inc. From our Stock News Alerts App
August 13th 2018, 10:08am
StockTexts @StockTexts
$BCRX BioCryst Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/x7zdKOrBZU
August 13th 2018, 10:08am
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals, Inc. $BCRX Given Consensus Rating of “Hold” by Analysts https://t.co/AatWhoerC1
August 13th 2018, 8:08am
stocknewsdotcom @stocknewsdotcom
$BCRX H.C. Wainwright & Co. reiterates Buy rating, $13 PT https://t.co/fF2Gh9junu
August 13th 2018, 8:08am
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Upgraded by BidaskClub to “Buy” https://t.co/pX68dmsZ67
August 13th 2018, 7:08am
TheMarketsDaily @TheMarketsDaily
BioCryst Pharmaceuticals $BCRX Given Buy Rating at HC Wainwright https://t.co/qpNEYH4fsk
August 13th 2018, 7:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.